Abrams Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-24,800,355
| Closed | -$17.1M | – | 20 |
|
|
2020
Q4 | $17.1M | Buy |
24,800,355
+10,000,000
| +68% | +$6.9M | 0.48% | 15 |
|
|
2020
Q3 | $33.3M | Sell |
14,800,355
-8,402,514
| -36% | -$18.9M | 1.05% | 16 |
|
|
2020
Q2 | $83.1M | Hold |
23,202,869
| – | – | 2.68% | 14 |
|
|
2020
Q1 | $88.2M | Hold |
23,202,869
| – | – | 3.47% | 13 |
|
|
2019
Q4 | $69.8M | Buy |
+23,202,869
| New | +$69.8M | 2.17% | 14 |
|